Decision Analysis in Pediatric Hematology

Pediatric Clinics of North America

Volumn 55, Issue 2, 2008, Pages 287-304

  O'Brien, Sarah H ^a,b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; CORTICOSTEROID DERIVATIVE; HEMOSTATIC AGENT; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; RECOMBINANT ERYTHROPOIETIN; RHESUS D ANTIBODY; ZIDOVUDINE;

BLOOD TRANSFUSION; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; DISEASE SEVERITY; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEMATOLOGIC DISEASE; HEMOPHILIA A; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LEARNING; LEUKEMIA; LEUKOPENIA; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL RESEARCH; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; REVIEW; SICKLE CELL ANEMIA; THROMBOCYTOPENIA; TREATMENT OUTCOME;

DECISION SUPPORT TECHNIQUES; DECISION TREES; HEMATOLOGY; HUMANS; PEDIATRICS;

EID: 41149177608     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2008.01.004     Document Type: Review

References (43)

1. Hulley S.B. Research using existing data: secondary data analysis, ancillary studies, and systematic reviews. In: Hulley S.B., Cummings S.R., and Browner W.S. (Eds). Designing clinical research. 2nd edition (2001), Lippincott Williams & Wilkins, Philadelphia 195-212
2. Cook D.J., Greengold N.L., Ellrodt A.G., et al. The relation between systematic reviews and practice guidelines. Ann Intern Med 127 (1997) 210-216
3. Weinstein M.C., and Fineberg H.V. Clinical decision analysis (1980), W.B. Saunders, Philadelphia
4. Albert D.A. Decision theory in medicine: a review and critique. Milbank Mem Fund Q Health Soc 56 (1978) 362-401
5. Detsky A.S., Naglie G., Krahn M.D., et al. Primer on medical decision analysis: part 1-getting started. Med Decis Making 17 (1997) 123-125
6. Adams R.J., McKie V.C., Hsu L., et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 339 (1998) 5-11
7. Male C., Chait P., Ginsberg J.S., et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic antithrombin replacement in kids with all treated with asparaginase. Thromb Haemost 87 (2002) 593-598
8. Maxwell D. Improving hard decisions: biennial survey of decision analysis software offers side-by-side comparison of critical O.R. tools. OR/MS Today 33 6 (2006)
9. Sonnenberg F.A., and Beck J.R. Markov models in medical decision making: a practical guide. Med Decis Making 13 (1993) 322-338
10. Burd R.S., and Sonnenberg F.A. Decision analysis: a basic overview for the pediatric surgeon. Semin Pediatr Surg 11 (2002) 46-54
11. Bohn R.L., Colowick A.B., and Avorn J. Probabilities, costs, and outcomes: methodological issues in modelling haemophilia treatment. Haemophilia 5 (1999) 374-377
12. Drug topics red book (2006), Medical Economics, Montvale (NY)
13. US Department of Health and Human Services. Centers for Medicare and Medicaid services. Available at:. http://www.cms.hhs.gov Accessed February 14, 2008
14. Weinstein M.C., Siegel J.E., Gold M.R., et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 276 (1996) 1253-1258
15. US Department of Labor. Bureau of Labor Statistics data. Available at:. http://www.bls.gov/data/home.htm Accessed February 14, 2008
16. Drummond M. Basic types of economic evaluation. In: Drummond M.F., Obrien B., Stoddard G.L., et al. (Eds). Methods for the economic evaluation of health care programmes. 2nd edition (1997), Oxford University Press, Oxford (UK) 6-26
17. Griebsch I., Coast J., and Brown J. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics 115 (2005) e600-e614
18. Drummond M.F., O'Brien B., Stoddart G.L., et al. Methods for the economic evaluation of health care programmes. 2nd edition (1997), Oxford University Press, Oxford (England); New York
19. Health Decision Strategies, LLC. Decision tools, questionnaires, and surveys. Available at:. http://www.healthstrategy.com/objectiv.htm Accessed February 15, 2008
20. Gold M.R., Franks P., McCoy K.I., et al. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 36 (1998) 778-792
21. Tengs T.O., and Wallace A. One thousand health-related quality-of-life estimates. Med Care 38 (2000) 583-637
22. Richardson W.S., and Detsky A.S. Users' guides to the medical literature. VII. How to use a clinical decision analysis. B. What are the results and will they help me in caring for my patients? Evidence based medicine working group. JAMA 273 (1995) 1610-1613
23. Weinstein M.C., and Fineberg H.V. Clinical decision analysis (1980), W.B. Saunders, Philadelphia
24. Elkin E.B., Vickers A.J., and Kattan M.W. Primer: using decision analysis to improve clinical decision making in urology. Nat Clin Pract Urol 3 (2006) 439-448
25. Hirth R.A., Chernew M.E., Miller E., et al. Willingness to pay for a quality-adjusted life year: in search of a standard. Med Decis Making 20 (2000) 332-342
26. Ubel P.A., Hirth R.A., Chernew M.E., et al. What is the price of life and why doesn't it increase at the rate of inflation?. Arch Intern Med 163 (2003) 1637-1641
27. O'Brien S.H., Ritchey A.K., and Smith K.J. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP). Pediatr Blood Cancer 48 (2007) 173-180
28. Briggs A.H., Goeree R., Blackhouse G., et al. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making 22 (2002) 290-308
29. Colowick A.B., Bohn R.L., Avorn J., et al. Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper. Blood 96 (2000) 1698-1702
30. Nietert P.J., Abboud M.R., Silverstein M.D., et al. Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood 95 (2000) 3057-3064
31. Hankins J., Hinds P., Day S., et al. Therapy preference and decision-making among patients with severe sickle cell anemia and their families. Pediatr Blood Cancer 48 (2007) 705-710
32. Klaassen R.J., Doyle J.J., Krahn M.D., et al. Initial bone marrow aspiration in childhood idiopathic thrombocytopenia: decision analysis. J Pediatr Hematol Oncol 23 (2001) 511-518
33. Centre for Review and Dissemination. National Health Service economic evaluation database. Available at:. http://www.york.ac.uk/ubst/crd/crddatabases.htm Accessed February 15, 2008
34. Richardson W.S., and Detsky A.S. Users' guides to the medical literature. VII. How to use a clinical decision analysis. A. Are the results of the study valid? Evidence-based medicine working group. JAMA 273 (1995) 1292-1295
35. Naimark D., Naglie G., and Detsky A.S. The meaning of life expectancy: what is a clinically significant gain?. J Gen Intern Med 9 (1994) 702-707
36. Tsevat J., Weinstein M.C., Williams L.W., et al. Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation 83 (1991) 1194-1201
37. Goel V. Decision analysis: applications and limitations. The health services research group. CMAJ 147 (1992) 413-417
38. TreeAge Software, Inc. TreeAge software training. Available at:. http://server.treeage.com/treeagepro/training/index.asp Accessed February 17, 2008
39. Allen U.D., Kirby M.A., and Goeree R. Cost-effectiveness of recombinant human erythropoietin versus transfusions in the treatment of zidovudine-related anemia in HIV-infected children. Pediatr AIDS HIV Infect 8 (1997) 4-11
40. Killie M.K., Kjeldsen-Kragh J., Husebekk A., et al. Cost-effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia. BJOG 114 (2007) 588-595
41. Mazumdar M., Heeney M.M., Sox C.M., et al. Preventing stroke among children with sickle cell anemia: an analysis of strategies that involve transcranial Doppler testing and chronic transfusion. Pediatrics 120 (2007) e1107-e1116
42. Panepinto J.A., Magid D., Rewers M.J., et al. Universal versus targeted screening of infants for sickle cell disease: a cost-effectiveness analysis. J Pediatr 136 (2000) 201-208
43. Thung S.F., and Grobman W.A. The cost effectiveness of empiric intravenous immunoglobulin for the antepartum treatment of fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 193 (2005) 1094-1099